MYCOPLASMA GENITALIUM A PRACTICAL GUIDE
|
|
- Angelina Paula Ferguson
- 5 years ago
- Views:
Transcription
1 MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1
2 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE ANTIBIOTICS OFTEN MULTIPLE PRACTITIONERS ANTIBIOTIC RESISTANCE ACCESS TO TREATMENT TIMEFRAMES 2
3 MYCOPLASMA GENITALIUM A PRACTICAL GUIDE WHO TO TEST TESTS FROM WHERE WITH WHAT MANAGEMENT OF POSITIVE TESTS TREATMENT SEXUAL CONTACTS TEST OF CURE 3
4 BOTTOM LINE DOXYCYCLINE FIRST LINE FOR NON GONOCOCCAL URETHRITIS TALK TO LABORATORY PREVENTION REINFECTION - CONDOMS CAN BE FRUSTRATING ASK ADVICE MYCOPLASMA IS ONE OF THE CAUSES OF URETHRITIS 4
5 TESTING WHO SYMPTOMATIC RECURRENT OR PERSISTENT URETHRITIS PID NOT RESPONDED TO TREATMENT CERVICITIS NOT RESPONDED TO TREATMENT CONTACTS LAST 3/12 HOW URETHRAL FVU CERVICAL RECTAL BE VERY CLEAR ON LAB FORM WHAT YOU ARE REQUESTING 5 TEST OF CURE 3/52
6 6
7 MANAGEMENT OF POSITIVE TESTS TREATMENT 500MG OF AZITHROMYCIN DAY 1, THEN 250MG DAILY DAYS 2-5 IF ALREADY HAD AZITHROMYCIN MOXIFLOXACIN 400MG DAILY FOR 7 DAYS - SPECIAL AUTHORITY MACROLIDE RESISTANT MOXIFLOXACIN 400MG DAILY FOR 7 DAYS SPECIAL AUTHORITY APPLY FOR WAIVER 7
8 RE SPECIAL AUTHORITY APPLICATIONS. IF YOU HAVE ANY QUERIES REGARDING THE PROCESSING OF PAPER BASED OR DECLINED SPECIAL AUTHORITY APPLICATIONS, PLEASE CONTACT SECTOR SERVICES ON CALL TO DISCUSS FAST-TRACKING APPLICATION AND WAIVERS 8
9 MANAGEMENT OF POSITIVE TESTS DISCUSS CONDITION GIVE WRITTEN INFORMATION CONTACT TRACING 3/12 AVOID REINFECTION NO SEX UNTIL 1/52 POST TREATMENT THEN CONDOMS UNTIL NEG TOC 1/52 FOLLOW UP VISIT/CALL TOC 3/52 9
10 10
11 FOLLOW UP RESULTS 1/52 FOLLOW UP VISIT/CALL SYMPTOM RESOLUTION ADHERENCE TO TREATMENT CONTACT TRACING RISK REINFECTION REMIND RE NO SEX UNTIL 1/52 AFTER COMPLETION TREATMENT THEN CONDOMS UNTIL NEGATIVE TOC BOOK TOC IF NOT ALREADY DONE SO ADD TO RECALL SYSTEM TEST OF CURE 3/52 IF POSITIVE TREATMENT DEPENDS ON: PREVIOUS TREATMENTS? REINFECTION? RESISTANT 11
12 MANAGEMENT SEXUAL CONTACTS BE CLEAR CONTACT OF M. GENITALIUM WRITE IT / TEXT IT / PRINT IT!!!!!!! CONTACTS PENILE / VAGINAL / ANO-RECTAL 3/12 TEST? TREAT BEFORE RESULTS SYMPTOMATIC AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 ASYMPTOMATIC DEPENDS ON HISTORY EXPOSURE NO SEX WITH SEXUAL CONTACTS FROM THE LAST 3 MONTHS UNTIL 7 DAYS AFTER BOTH THE PATIENT AND ONGOING SEXUAL CONTACTS HAVE COMPLETED THEIR TREATMENT, THEN CONDOMS UNTIL BOTH NEGATIVE TOC 12
13 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 1 FROM ONSET SYMPTOMS 1/52 Urethral irritation Penile discharge, clear WHAT DO YOU DO? Background 2/7 ago penetrative penile anal no condom, partner, regular sexual contact 3/52 ago receptive penile anal, condom, regular sexual contact 3/12 ago, penetrative penile vaginal, condom STI screening 12/12 ago NAD Nil else of note O/E NAD except clear colourless fluid urethral meatus 13
14 TREATMENT URETHRITIS DOXYCYCLINE 100MG BD 1/52 DISCUSS DIAGNOSIS URETHRITIS TEST CHLAMYDIA AND GONORRHOEA NAAT PO PA FVU SEROLOGY HIV, SYPHILIS EXPLANATION OF WHAT TESTING FOR INCLUDING WINDOW PERIODS ETC DISCUSS + OFFER CONDOM NO SEX UNTIL 7/7 AFTER COMPLETED TREATMENT CHECK CONTACT DETAILS FOR TEST RESULTS DISCUSS CONTACT TRACING LAST 2/12 FOLLOW UP 1/52 14
15 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 3 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS DOXYCYCLINE 100MG BD 1/52 WHAT DO YOU DO? 2/52 TESTS NAD CALLED TO GIVE RESULTS, NO ANSWER, DIDN T REPLY TO MESSAGES 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC HAS FOLLOWED YOUR ADVICE EXAM NAD 15
16 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 3 FROM ONSET SYMPTOMS Persistent urethritis o Discuss possible causes including M.genitalium o Testing M. genitalium FVU, rectal swab, timeframe results other testing as guided by history and exam findings o Treatment o Azithromycin 500mg day 1, then 250mg days Metronidazole 400mg bd 1/52 o If already treated with Azithromycin 1g, Doxycycline 100mg bd 1/52 o Re reinfection + transmission no sex until 1/52 post completion treatment 16 CONDOMS o Contact tracing 3/12
17 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM WHAT DO YOU DO? 18
18 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM PLAN DISCUSS + GIVE WRITTEN INFO CHECK SYMPTOMS CONTACT TRACING ENSURE THEY KNOW ITS M.GENITALIUM DISCUSSION TRANSMISSION REINFECTION CONDOMS IF ASYMPTOMATIC TOC 3/52 19
19 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 8 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM ASYMPTOMATIC 6/52 TEST OF CURE 8/52 NEGATIVE M GENITALIUM 20
20 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM IF STILL HAS SYMPTOMS WHAT DO YOU DO? 21
21 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM IF STILL HAS SYMPTOMS MOXIFLOXACIN 400MG OD 7/7 WRITTEN INFO DISCUSSION TRANSMISSION REINFECTION CONTACT TRACING ENSURE THEY KNOW ITS M.GENITALIUM CONDOMS 1/52 FOLLOW UP TOC 3/52 22
22 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 NEGATIVE M GENITALIUM 23
23 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 POSITIVE M GENITALIUM SEEK ADVICE! 24
24 32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 NEGATIVE M GENITALIUM BUT WHAT ABOUT THE CONTACTS?! 1. 2/7 AGO PENETRATIVE PENILE ANAL NO CONDOM, PARTNER, REGULAR SEXUAL CONTACT 2. 3/52 AGO RECEPTIVE PENILE ANAL, CONDOM, REGULAR SEXUAL CONTACT 3. 3/12 AGO, PENETRATIVE PENILE VAGINAL, CONDOM 26
25 INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSON HAS HAD DOXYCYCLINE, NO BETTER, NOW HAVING AZITHROMYCIN 500MG D1, 250MG DAY 2-5 THEY HAVE REGULAR PENILE ANAL SEXUAL CONTACT CONDOMLESS AWARE MG TESTING, NO RESULT YET SYMPTOMATIC URETHRITIS BARRIERS TO CONDOM USE CLEAR URETHRAL DISCHARGE MEATUS WHAT DO YOU DO? 27
26 INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSON HAS HAD DOXYCYCLINE, NO BETTER, NOW HAVING AZITHROMYCIN 500MG D1, 250MG DAY 2-5 THEY HAVE REGULAR PENILE ANAL SEXUAL CONTACT CONDOMLESS AWARE MG TESTING, NO RESULT YET SYMPTOMATIC URETHRITIS BARRIERS TO CONDOM USE CLEAR URETHRAL DISCHARGE MEATUS PLAN TEST FVU + RECTAL SWAB EPIDEMIOLOGICAL TREATMENT WITH AZITHROMYCIN 500MG OD, 250MG OD DAYS 2-5 ALSO REITERATE NO SEX RESISTANT BUGS CONDOMS (DONT FORGET CONSIDERING OTHER CAUSES URETHRITIS, STI TESTING, FOLLOW UP RESULTS ETC) \ 28
27 ASYMPTOMATIC CONTACT 7 WEEKS FROM START INDEX PERSONS SYMPTOMS ASYMPTOMATIC CONTACT WHAT WOULD YOU DO? REGULAR ANAL RECEPTIVE AND INSERTIVE, CONDOMS NOT HAD SEX WITH INDEX CASE 7/52 TEXT SAYING TREATED STI BEEN TESTED AND NAD, ANOTHER SAYING?MG 29
28 ASYMPTOMATIC CONTACT 7 WEEKS FROM START INDEX PERSONS SYMPTOMS ASYMPTOMATIC CONTACT REGULAR ANAL RECEPTIVE AND INSERTIVE NOT HAD SEX WITH INDEX CASE 7/52 TEXT SAYING TREATED STI BEEN TESTED AND NAD, ANOTHER SAYING?MG AZITHROMYCIN 5/7 PLAN - TEST AND WAIT - IF SYMPTOMATIC - AZITHROMYCIN 500MG DAY 1, 250MG DAYS ALSO USUAL CONSULTATION HAVE WITH CONTACTS, STI TESTING ETC 30
29 ASYMPTOMATIC CONTACT 10 WEEKS FROM START INDEX PERSONS SYMPTOMS 3 /12 AGO WHAT DO YOU DO? RECEPTIVE PENILE VAGINAL CONDOM NO SYMPTOMS EXAMINATION NAD 31
30 ASYMPTOMATIC CONTACT 10 WEEKS FROM START INDEX PERSONS SYMPTOMS 3 1/12 AGO RECEPTIVE PENILE VAGINAL X1 CONDOM NO SYMPTOMS PLAN - TEST AND WAIT - IF SYMPTOMATIC / INDICATIVE FINDINGS -? ANY MORE INFORMATION AVAILABLE RE TEST RESULTS AND TREATMENTS? - AZITHROMYCIN 500MG DAY 1, 250MG DAYS ALSO USUAL CONSULTATION HAVE WITH CONTACTS, STI TESTING ETC 32
31 MYCOPLASMA GENITALIUM A PRACTICAL GUIDE USE DOXYCYCLINE FOR PEOPLE WHO PRESENT WITH URETHRITIS THAT YOU DON T THINK IS CAUSED BY GONORRHOEA M.GENITALIUM TREATED WITH AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 MOXIFLOXACIN 400MG OD 7/7 SPEAK TO SPECIAL AUTHORITY TEAM CAN FASTTRACK AND DO WAIVERS FOR MACROLIDE RESISTANT TESTING KNOW HOW TO ORDER SPEAK TO YOUR LAB WHAT TO USE BE CLEAR ON THE LAB FORM BE MINDFUL OF THE TIMEFRAMES AND POTENTIAL DELAYS! PRESENTATIONS, TESTING, RESULTS, APPROVAL FOR MEDS, GETTING THE MEDS, TAKING THE MEDS.TESTS OF CURE AND CONTACT TRACING WITH RISKS REINFECTION AS WELL AS RESISTANCE WRITE MYCOPLASMA GENITALIUM DOWN / TEXT / PRINT INFO FOR PEOPLE SO CONTACTS CAN BE TESTED AND TREATED APPROPRIATELY ASK FOR ADVICE 33
32 REFERENCES NZ SHS WEBSITE EUROPEAN GUIDELINES MG BASHH URETHRITIS SPECIAL AUTHORITY FORMS 34
Management of NGU (Non-gonococcal urethritis)
Management of NGU (Non-gonococcal urethritis) First line Doxycycline 100mg po bd for 7 days (contra-indicated in pregnancy) Alternative regimens Azithromycin 1G po stat Azithromycin 500mg po stat, then
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationClinical Guidelines Update (aka Know Your NAATs)
Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationMycoplasma Genitalium: Get to Know the Hidden STI
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/mycoplasma-genitalium-get-to-know-hiddensti/9501/
More informationMycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE
Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE Overview Introduction to Mycoplasma genitalium Audit Objectives Standards Results Reflection AFPHM learning objectives
More informationDr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch
Dr Edward Coughlan Clinical Director Christchurch Sexual Health Christchurch 16:30-17:25 WS #48: Mycoplasma Genitalium - The New Black 17:35-18:30 WS #58: Mycoplasma Genitalium - The New Black (Repeated)
More informationTesting, Treating and Managing STIs Dr Jean Irvine
Testing, Treating and Managing STIs Dr Jean Irvine 1 Chlamydia 2 3 Chlamydia: key facts Intracellular bacterial infection Sexually transmitted: Vaginal sex Anal sex?oral sex Most common bacterial STI in
More informationAdvances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol
Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing
More informationJulie Nelson RNC/WHNP-BC Epidemiology NURS 6313
Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Chlamydia Most frequently reported bacterial STI in the US In 2006, In U.S. 1,030,911 cases were reported. Estimated 2,291,000 infections in 14-39 year olds.
More informationOne week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection
One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationSTI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council
STI & HIV screening in Primary Care Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council Outline Why Screen Advances in diagnostics how can we
More informationSTI control. Dr. Jane Morgan Hamilton Sexual Health Clinic
STI control Dr. Jane Morgan Hamilton Sexual Health Clinic Overview STI control in theory NZ s reality Where to from here? STI control framework R0=ßcD R0 = reproductive rate; the rate at which infection
More informationCheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document
Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document Clinical STI/HIV Care Pathway assumes appropriate competency verified (flow chart and explanatory notes to be read together)
More informationRISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS
RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS Warning: contains sexual themes and references! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz Updates
More informationCost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK
Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK Appendix 1 Model Assumptions All assumptions were confirmed and
More informationNon-gonococcal urethritis. Looking after your sexual health
Non-gonococcal urethritis Looking after your sexual health 2 3 Non-gonococcal urethritis Urethritis is inflammation (pain, redness or soreness) of the urethra (the tube that carries urine out of the body).
More informationGynaecology. Pelvic inflammatory disesase
Gynaecology د.شيماءعبداألميرالجميلي Pelvic inflammatory disesase Pelvic inflammatory disease (PID) is usually the result of infection ascending from the endocervix causing endometritis, salpingitis, parametritis,
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationResponsibilities in a sexual relationship - Contact tracing
P a g e 1 Responsibilities in a sexual relationship - Contact tracing This activity has been designed increase student familiarity with the NSW Health Play Safe website. Suggested duration: 50-60 minutes
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationExtragenital Gonorrhea and Chlamydia among MSM
Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org
More informationSTIs in Primary Care. Dr Eleanor Draeger 19 th January 2016
STIs in Primary Care Dr Eleanor Draeger 19 th January 2016 Poli=cs! 2012! Health and Social Care act! Sexual Health commissioning moved to local authority! 2015! 200 million cuts to public health! 40%
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationA healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health
2018 A healthy respect for Sexual Health Dee Archbold CNC Princess Alexandra Sexual Health Princess Alexandra Sexual Health (PASH) Sexual health service for Metro South (estimated >1million residents and
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationSTI Diagnostics Redesign. HVS and Chlamydia Resource Pack
Important! 1. This information is intended to support practitioners in the management of common sexual health problems and it is therefore essential that each doctor and nurse receives a copy. 2. Future
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationONLINE SUPPLEMENTARY MATERIALS: FILE 1
ONLINE SUPPLEMENTARY MATERIALS: FILE 1 Clinical care pathways using chlamydia and gonorrhoea tests are evolving: point of care nucleic acid amplification tests may reduce genitourinary medicine service
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationTRICHOMONAS VAGINALIS
TRICHOMONAS VAGINALIS What s New: There are no changes to this guideline. Introduction Trichomonas vaginalis (TV) is a flagellated protozoan that is a parasite of the genital tract. Due to site specificity,
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More informationWelcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.
Welcome to: Coding Scenarios for STD Clinic Visits We will begin in a few minutes. There will be no sound until the webinar starts. Welcome to: Coding Scenarios for STD Clinic Visits You are using audio
More information25/02/2016. New onset low abdominal pain in women of reproductive age. New onset low abdominal pain: why it matters?
New onset in women of reproductive age Dr Deborah Bateson Medical Director Family Planning NSW Chair Australasian Sexual Health Alliance why it matters? Can be fatal (consider ectopic pregnancy in all
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationGuidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:
Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes
More informationDr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014
THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Selena Singh Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Performance of ceftriaxone 500mgcontaining
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationPrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV.
PrEP in Scotland PrEP PrEP PrEP PrEP is a combination pill that prevents HIV. 1 Contents Introduction 3 What is PrEP 3 Who should take PrEP 4 Getting PrEP in Scotland 5 Side effects and interactions with
More informationScreening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016
Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary
More informationSexual health screening
Sexual health screening This guideline provides screening recommendations that are based on anatomy and is inclusive of genderaffirming surgeries and hormone therapy. All patients should be screened according
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationMSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs
Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient
More informationClinical Cases from the STD Clinical Consultation Network
Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850 STD Clinical Consultation Network (STDCCN) Developed
More informationGAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016
GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know
More informationMG and PID. Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service
MG and PID Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service MG and NGNCU Strong relationship between M. genitalium and NGNCU Taylor-Robinson et al. 2011 Clin. Micro. Rev;24(3):498 MG
More informationLET S TALK about Sticking with your treatment plan
LET S TALK about Sticking with your treatment plan HOW ONGOING HIV CARE HELPS YOU LIVE A LONGER AND HEALTHIER LIFE Your treatment plan is vital to your overall health (and to reducing HIV transmission)
More informationSex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs)
Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs) Self-Advocacy Educator - Max Barrows Sex Educator - Katherine McLaughlin www.elevatustraining.com Sex Educator
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationDisclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI. Friday, MARCH 20, 2015 STUDENT COPY
MHD II, Session VI, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI Friday, MARCH 20, 2015 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationClinical Education Initiative URETHRITIS. Elizabeth Asiago-Reddy, MD
Clinical Education Initiative Support@ceitraining.org URETHRITIS Elizabeth Asiago-Reddy, MD 3/13/2017 Urethritis [video transcript] 00:00:07 - [Elizabeth] Thanks so much for having me and I'm sorry for
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationGP Perspective about prescribing PEP & PrEP
GP Perspective about prescribing PEP & PrEP Dr Garsing Wong, Auckland Central Medical and Health Centre, 326/28 College Hill, Freemans Bay, Auckland 1011 akcentralmedical@gmail.com 09 360 0250 Disclosures
More informationClinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP
Clinical Education Initiative Support@ceitraining.org TITLE: UPDATE ON MSM SEXUAL HEALTH Speaker: Maureen Scahill, MS NP 1/25/2017 2/10/2017 Update on MSM Sexual Health [video transcript] 00:00:08 - [Maureen]
More informationSEXUALLY TRANSMITTED INFECTIONS (STIS)
SEXUALLY TRANSMITTED INFECTIONS (STIS) CONTENTS Causes Prevention Methods of Transmission Decisions to Have Sexual Intercourse Signs and symptoms Screening Pop Quiz Diagnosis Management: Public Health
More informationSexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016
Sexually Transmitted Infection surveillance in Northern Ireland 2017 An analysis of data for the calendar year 2016 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:
More informationAPPENDIX A SERVICE SPECIFICATION
Service Specification No. Service Authority Lead Provider Lead 2013/14 APPENDIX A SERVICE SPECIFICATION Participation in the Ruclear chlamydia and gonorrhoea screening programme (General practices) Period
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationPartner Counseling and Referral Services
Partner Counseling and Referral Services Presented at the Sexually Transmitted Disease (STD) Intensive Course Cleveland, OH June 22, 2012 Rhiannon Richman, MPH Infertility Prevention Project Coordinator
More informationSexually Transmitted Diseases. Chlamydial. infection. Questions and Answers
Sexually Transmitted Diseases Chlamydial infection Questions and Answers What is chlamydial infection? It is a sexually transmitted infection caused by the bacteria Chlamydia trachomatis, being one of
More informationSexual Health reproduction in reference to treatment as/for prevention
Sexual Health reproduction in reference to treatment as/for prevention The reasons for sexual reproductive health for PLHIV The number of people living with HIV (PLWH) continues to rise in the UK The increase
More informationUniversity Health Services at CMU STI Awareness Month specials for students:
University Health Services at CMU STI Awareness Month specials for students: -Free condoms during April (10 per student) -Free walk-in rapid HIV testing April 22-27 (no appointment needed) -STI Screening
More informationThat Other Chlamydia: Lymphogranulom a Venereum (LGV)
Clinical Education Initiative Support@ceitraining.org That Other Chlamydia: Lymphogranulom a Venereum (LGV) Speaker: Marguerite Urban, MD 4/4/2018 That Other Chlamydia: Lymphogranuloma Venereum (LGV) [video
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY
MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationHow to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP?
4 What is PrEP? 6 Who will benefit from PrEP? 7 Men (cis or trans) and trans women who have sex with men Partners of people living with HIV 8 Take the quiz: Is PrEP right for me? What are the options for
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationControl and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis. Dr Nathalie Broutet Department of Reproductive Health and Research
Control and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis Dr Nathalie Broutet Department of Reproductive Health and Research Intervention Effects Level Levels at which STI have
More informationLove Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine
Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine 37 th Annual Sanford Black Hills Pediatric Symposium June 26,
More informationPeople with genital herpes require enough information and medication (when indicated) to self-manage their condition.
Genital Herpes Summary of Guidelines Taken from: Guidelines for the Management of Genital Herpes in New Zealand 11th Edition - 2015 www.herpes.org.nz Genital Herpes Key Management Points Genital herpes
More informationSTIs and BBVs. The facts
EASY ENGLISH STIs and BBVs Some people say sex germs The facts New words There may be words in this factsheet that are new to you and you may not know what they mean or you may be unsure what they mean.
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL
DISCLOSURE PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Dr. Feller does not have any actual or potential conflicts of interest to disclose and will not be discussing
More informationTDL Sexual Health 2019
TDL Sexual Health 019 Sexual Health Screening services continue to become easier to access for everyone, with testing and results becoming available more quickly through both private, NHS clinics, and
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationProfessor Jonathan Ross
SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received
More informationPARTICIPANT DIARY TREATMENT ALLOCATION: LACTIC ACID GEL
PARTICIPANT DIARY TREATMENT ALLOCATION: LACTIC ACID GEL For site staff completion only: Participating Site: Participant Initials: Participant ID: Date of Randomisation: Allocated Treatment: Lactic Acid
More informationPARTICIPANT DIARY TREATMENT ALLOCATION: ORAL METRONIDAZOLE TABLETS
PARTICIPANT DIARY TREATMENT ALLOCATION: ORAL METRONIDAZOLE TABLETS For site staff completion only: Participating Site: Participant Initials: Participant ID: Date of Randomisation: Allocated Treatment:
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL
PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Jade Feller, PharmD PGY-1 Pharmacy Resident Iowa City Veterans Affairs Health Care System November 13, 2018 DISCLOSURE
More informationUpdate on Sexual Health: Screening, Diagnosing and Treating STIs
Update on Sexual Health: Screening, Diagnosing and Treating STIs Dr Gila Metz Medical Director, Health Sexuality and Risk Reduction Unit Ottawa Public Health November 28, 2013 Objectives To review current
More informationLEARNING NATIONAL CURRICULUM. Herpes virus. This section aims to teach students how sexual activity can lead to the spread of microbes and disease.
This section aims to teach students how sexual activity can lead to the spread of microbes and disease. Section 2.3, Sexually Transmitted Infections, teaches students how easily potentially harmful microbes
More informationPART 3: HOW TO PROVIDE STI TEST RESULTS
PART 3: HOW TO PROVIDE STI TEST RESULTS HOW TO PROVIDE STI TEST RESULTS When an individual receives a positive result, providers are required by law to provide treatment or refer the patient to treatment
More informationAsk at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?
Essential Sexual Health Questions to Ask Adults Ask all of your adult patients the sexual health questions on this card. They will help you assess the patient s level of sexual risk and determine whether
More information